Genotyping Assay Market Trends That Will Shape the Next Decade: Insights from CE-IVD Marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit For Treatment-Resistant Strains Of HIV-1

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Genotyping Assay Market Size By 2025?
The market for genotyping assays has seen extraordinary expansion lately, projected to increase its valuation from $33.98 billion in 2024 to reach $41.31 billion by 2025, reflecting an impressive compound annual growth rate (CAGR) of 21.6%. This historical upswing has been fueled by various determinants, including the persistent utilization of conventional glassware, the impact of societal norms and ways of living, prevailing economic conditions, the burgeoning hospitality and foodservice sector, and shifting preferences related to presents and interior decoration.

How Big Is the Genotyping Assay Market Size Expected to Grow by 2029?
The overall scale of the genotyping assay sector is projected to experience rapid expansion over the forthcoming years, reaching a valuation of $94.61 billion by 2029, driven by a compound annual growth rate (CAGR) of 23.0%. This significant upward trajectory during the projection timeframe is fueled by factors such as increasing demand for customized and personalized offerings, prevalent health and wellness movements, the proliferation of e-commerce platforms, advancements in smart and functional glassware, and evolving trends within culinary arts and mixology, while prevailing industry shifts encompass advancements in material science, the introduction of novel forms and aesthetics, the integration of smart technology into glassware, the development of glassware specifically designed for various beverages, and an enhanced focus on incorporating health and safety attributes.

View the full report here:
https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report

Which Key Market Drivers Powering Genotyping Assay Market Expansion and Growth?
The rising incidence of ailments rooted in genetics is anticipated to be a major catalyst for the expansion of the genotyping assay market in the near future. These medical conditions arise from deviations or alterations within a person's DNA structure, and genotyping tests function by contrasting the genetic material of affected individuals with that of healthy controls to pinpoint specific mutations or variations associated with a given genetic illness. To illustrate the scale, in June 2023, the UK charity Gene People, which aids those with genetic conditions, publicly stated that a worrying one in 25 newborns in the UK suffers from such a disorder, translating to roughly 30,000 infants and young children annually, impacting over 2.4 million people of all ages across the nation each year; consequently, this heightened frequency of genetic disorders directly fuels the upward trajectory of the genotyping assay market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13444&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Genotyping Assay Market?
Key players within the genotyping assay sector are focusing efforts on innovations in genetic studies, notably the introduction of CE-IVD designated assays aimed at identifying HIV-1 strains that exhibit resistance to therapy. Specifically, the CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit constitutes an analysis method utilizing Sanger sequencing principles, employed to scrutinize samples positive for human immunodeficiency virus (HIV) to pinpoint genetic variations potentially evading standard antiretroviral medications. Illustratively, in January of 2023, the American enterprise Thermo Fisher Scientific released this very product, the CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit; this platform offers capabilities such as evaluating genetic alterations, utilizing HIV RNA for analysis, identifying mutations conferring drug resistance, employing the benchmark Sanger sequencing technique, and being explicitly purposed for clinical applications while simultaneously confirming the presence of therapy-resistant HIV-1 variants. The introduction of the Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit brought significant benefits, enhancing the identification accuracy of treatment-resistant HIV-1 strains, supplying pre-validated reagents and reference materials, satisfying necessary compliance standards, demonstrating superior operational metrics, and ensuring seamless integration with current sequencing infrastructure and laboratory procedures.

What Are the Emerging Segments in the Genotyping Assay Market?
The genotyping assaymarket covered in this report is segmented -

1) By Product And Service: Reagents And Kits; Genotyping Services; Instruments; Bioinformatics
2) By Technology: Microarrays; Polymerase Chain Reaction; Sequencing; Capillary Electrophoresis; Matrix-assisted Laser Desorption Or Ionization-Time Of Flight Mass Spectrometry; Other Technologies
3) By End-User: Pharmacogenomics; Personalized Medicine And Diagnostics; Animal Genetics; Agricultural Biotechnology; Research And Diagnostic Laboratories; Academic Institutes

Subsegments:
1) By Reagents And Kits: DNA Extraction Kits; PCR Reagents; SNP Genotyping Kits; Genotyping Services; Genotyping by PCR; Whole Genome Sequencing Services; SNP Genotyping Services
2) By Instruments: PCR Machines; Sequencing Instruments; Microarrays
3) By Bioinformatics: Data Analysis Software; Genotyping Data Management Tools

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13444&type=smp

Who Are the Global Leaders in the Genotyping Assay Market?
Major companies operating in the genotyping assay market report are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv Inc., Promega Corporation, Luminex Corporation, Integrated DNA Technologies Inc., Integrated DNA Technologies Ltd., Sequenom Inc., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies PLC, GenMark Diagnostics Inc., Macrogen Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Genewiz Inc., New England Biolabs, TrimGen Corporation, Xcelris Genomics

Which are the Top Profitable Regional Markets for the Genotyping Assay Industry?
North America was the largest region in the genotyping assay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genotyping assay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13444

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.